Cigarette smoking has been associated with the development of many chronic diseases, including type 2 diabetes mellitus (T2DM), hypertension, and stroke. 1, 2 This has been attributed to tobacco-induced oxidants, inflammation, and insulin resistance.
The Mediterranean island of Malta has an established high prevalence of dysglycemia. 4 Malta is a small island nation. This makes it feasible to construct and conduct a cross-sectional study to establish the smoking determinants of diabetes mellitus at a population level. The aim of this study was to establish the prevalence of current, former, and passive smoking and their relationships with anthropometric and biochemical variables within the general and the dysglycemic population of Malta. Study objectives included the establishment of any association between smoking habits and dysglycemic status, namely impaired fasting blood glucose (IFG) and T2DM.
Methods
A national representative health examination survey was conducted among adults in Malta (2014-2016). Detailed methodology is provided elsewhere. 5 The different smoking habits (current, former, and passive smoking) were gathered through a validated questionnaire. Biochemical tests incorporating measurement of fasting blood glucose (FBG) and lipid profile were performed.
Participants with FBG between 5.6 and 6.9 mmol/L were classified as IFG, whereas those with FBG ≥7 mmol/L were categorized as newly diagnosed T2DM. Participants with a previous history of diabetes mellitus or on oral hypoglycemic agents, regardless of their plasma glucose concentrations, were classified as cases of known T2DM. The newly diagnosed T2DM and known T2DM populations were combined to represent the total T2DM population.
Participants reporting smoking more than 1 cigarette per day were considered current smokers. Individuals who had quit smoking for at least a year were considered former smokers. Smokers reporting to have stopped smoking for <1 year were still considered current smokers based on the World Health Organization report. 6 Individuals who denied active smoking but reported exposure to cigarette smoke regularly at work or at home for more than an hour each day were considered passive smokers. The remaining individuals were categorized as non-smokers.
Prevalence rates of each smoking subpopulation were calculated. The significance of differences between the different smoking subpopulations was evaluated using non-parametric tests. Generalized binary logistic regression models were performed to identify any associations between different smoking statuses (current, former, and passive) and the risk of developing T2DM and IFG. The non-smoker subgroup was used as the reference category for these models.
Ethics and data protection approvals were granted by the University of Malta Research Ethics Committee and the Information and Data Protection National Commissioner, respectively. Written informed consent was obtained from all participants.
Results
In this study (n = 3947; 1998 males), the prevalence of current tobacco smoking was 24.30% (95% confidence interval [ The biochemical and anthropometric profile for each smoking subgroup is given in Table 1 . Statistically significant differences were found between every biochemical and anthropometric parameter (except for total cholesterol) and the smoking subgroups.
Multivariate analysis revealed that only the former smokers exhibited an independent positive association (odds ratio [OR] 1.67; 95% CI 1.10-2.54; P = 0.02) of having dysglycemia (IFG and T2DM) compared with non-smokers and adjusting for confounding factors (ie, sex, education duration, employment status, alcohol habit, physical activity, obesity status, history of hypertension, history of dyslipidemia, and locality of residence).
Comments
Less than one-quarter of Maltese adults reported to be current smokers in this study. This proved to be a BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, Systolic blood pressure; TC, total cholesterol; TG, triglycerides; WC, waist circumference; WHR, waist: hip ratio. Unless indicated otherwise, data are given as the median (interquartile range).
higher prevalence than the neighboring country of Italy. 7 The former smoker population in this study exhibited increased body mass index, waist circumference, and waist: hip ratios compared with the other smoker subpopulations, which corresponds to the literature. 8 Furthermore, former smokers exhibited higher median FBG and triglyceride levels. In fact, former smoking was the only smoking status associated with concurrent dysglycemia. The causation for this relationship could not be established due to the nature of this study, but it appears to be independent of socioeconomic or lifestyle factors. On smoking cessation, individuals tend to consume high-sugar and fat-rich snacks to satisfy their cravings, which may be the case in this study. This will lead to an increase in adipose tissue (resulting in insulin resistance and eventual dysglycemia) and derangement of the lipid profile, including triglycerides. Other possible causes contributing to an increase in adipose tissue, leading to eventual dysglycemia, could be related to physiological changes, such as a reduction in metabolic rate following smoking cessation.
The benefits of quitting smoking by far outweigh the downside of the association with dysglycemia. Quitting is by no means an easy feat. Weight management programs, along with physiological support, should be incorporated into smoking cessation initiatives in order to maintain a successful smoke-free lifestyle.
